mailed
on 12 Jan 2024
Last Applicant/ Owned by
2-11-8 Shibadaimon
Minato-ku, Tokyo
JP
105-0012
Serial Number
97622009 filed on 06th Oct 2022
Registration Number
N/A
Correspondent Address
James J. Bosco, Jr., Registration No. 51
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Testing, analysis and evaluation for approval of goods and services of others to ensure compliance with industry standards; Research and development services in the field of pharmaceutical products; Research and development services in the field of antibodies; Laboratory research services in the field of pharmaceuticals using experimental animals; Cell culture services for scientific and research Read More
Testing, analysis and evaluation for approval of goods and services of others to ensure compliance with industry standards; Research and development services in the field of pharmaceutical products; Research and development services in the field of antibodies; Laboratory research services in the field of pharmaceuticals using experimental animals; Cell culture services for scientific and research purposes, for others; Stem cell research services; Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals, in vitro diagnostics, treatment or diagnostics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development support services, namely, pharmaceutical research and development; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment
Chemical reagents for medical purposes in the fields of cancer, cardiology, autoimmunity and immunological disorders, respiratory diseases, apoptosis, signal transduction, DNA, proteomics and genomics; Reagents for use in medical genetic testing; Immunoassay reagents for medical use; Diagnostic biomarker reagents for medical purposes; Companion diagnostics, namely, medical diagnostic reagents that assist in predicting the effects of a drug, the presence or absence of side effects, and the choice of patients to administer
No 97622009
No Service Mark
No 1217-2206716
No
No
No
No
No
No
No
No
The mark consists of MBL in a stylized blue font with the leg of the "L" curving upward.
| Status Date | Action Taken |
|---|---|
| 12th Apr 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 12th Apr 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 20th Feb 2024 | ASSIGNED TO EXAMINER |
| 12th Jan 2024 | FINAL REFUSAL WRITTEN |
| 12th Jan 2024 | FINAL REFUSAL E-MAILED |
| 12th Jan 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 06th Nov 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 06th Nov 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 06th Nov 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 04th Aug 2023 | NON-FINAL ACTION WRITTEN |
